Dr. Kenneth D. Noonan, Ph.D., serves as Member of Scientific Advisory Board at Integra Holdings and is a Venture Partner at Advanced Technology Ventures. Dr. Noonan focuses on life sciences, including pharmaceuticals, biopharmaceuticals, in vitro diagnostics and research products. Dr. Noonan is the Chief Executive Officer of Singapore Office at Lightstone Ventures. He focuses on life sciences, including pharmaceuticals, discovery and development services, in vitro diagnostics and research products. Dr. Noonan was previously a Venture Partner at the firm. He serves as the Managing Director of TK Associates. Dr. Noonan was the Head of European Life Sciences Practice and Senior Partner for L.E.K. Consulting LLP, since November 2001. Prior to joining L.E.K., Dr. Noonan was the Senior Vice President of Corporate Development at Applera Corporation, from 2000 to 2001, where Dr. Noonan had corporate responsibility for strategy and transactions. Dr. Noonan has served as a Director of Life Sciences International plc and Hyseq Inc. During his academic career, Dr. Noonan has authored over 50 articles in the area of cancer biology and cell replication. Dr. Noonan received his Ph.D. degree in Biochemistry from Princeton University and a B.S. degree in Biology from St. Joseph’s University.